» Articles » PMID: 33692827

Macrophage M2 Co-expression Factors Correlate With the Immune Microenvironment and Predict Outcome of Renal Clear Cell Carcinoma

Overview
Journal Front Genet
Date 2021 Mar 11
PMID 33692827
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

In the tumor microenvironment, the functional differences among various tumor-associated macrophages (TAM) are not completely clear. Tumor-associated macrophages are thought to promote the progression of cancer. This article focuses on exploring M2 macrophage-related factors and behaviors of renal clear cell carcinoma. We obtained renal clear cell carcinoma data from TCGA-KIRC-FPKM, GSE8050, GSE12606, GSE14762, and GSE3689. We used the "Cibersort" algorithm to calculate type M2 macrophage proportions among 22 types of immune cells. M2 macrophage-related co-expression module genes were selected using weighted gene co-expression network analysis (WGCNA). A renal clear cell carcinoma prognosis risk score was built based on M2 macrophage-related factors. The ROC curve and Kaplan-Meier analysis were performed to evacuate the risk score in various subgroups. The Pearson test was used to calculate correlations among M2 macrophage-related genes, clinical phenotype, immune phenotype, and tumor mutation burden (TMB). We measured differences in co-expression of genes at the protein level in clear renal cell carcinoma tissues. There were six M2 macrophage co-expressed genes (F13A1, FUCA1, SDCBP, VSIG4, HLA-E, TAP2) related to infiltration of M2 macrophages; these were enriched in neutrophil activation and involved in immune responses, antigen processing, and presentation of exogenous peptide antigen via MHC class I. M2-related factor frequencies were robust biomarkers for predicting the renal clear cell carcinoma patient clinical phenotype and immune microenvironment. The Cox regression model, built based on M2 macrophage-related factors, showed a close prognostic correlation (AUC = 0.78). The M2 macrophage-related prognosis model also performed well in various subgroups. Using western blotting, we found that VSIG4 protein expression levels were higher in clear renal cell carcinoma tissues than in normal tissues. These co-expressed genes were most related to the M2 macrophage phenotype. They correlated with the immune microenvironment and predicted outcomes of renal clear cell carcinoma. These co-expressed genes and the biological processes associated with them might provide the basis for new strategies to intervene via chemotaxis of M2 macrophages.

Citing Articles

Identification of signatures associated with microsatellite instability and immune characteristics to predict the prognostic risk of colon cancer.

Bo S, You Y, Wang Y, Zhang Y, Bai B, Jiang T Open Med (Wars). 2024; 19(1):20241056.

PMID: 39726813 PMC: 11669901. DOI: 10.1515/med-2024-1056.


CTCF-activated FUCA1 functions as a tumor suppressor by promoting autophagy flux and serum α-L-fucosidase serves as a potential biomarker for prognosis in ccRCC.

Zhao S, Sun J, Chang Q, Pang S, Zhang N, Fan Y Cancer Cell Int. 2024; 24(1):327.

PMID: 39342260 PMC: 11439243. DOI: 10.1186/s12935-024-03502-2.


Aging human abdominal subcutaneous white adipose tissue at single cell resolution.

Whytock K, Divoux A, Sun Y, Pino M, Yu G, Jin C Aging Cell. 2024; 23(11):e14287.

PMID: 39141531 PMC: 11561672. DOI: 10.1111/acel.14287.


Identification of macrophage differentiation related genes and subtypes linking atherosclerosis plaque processing and metabolic syndrome via integrated bulk and single-cell sequence analysis.

Ning D, Zhou Z, Zhou S, Chen J Heliyon. 2024; 10(14):e34295.

PMID: 39130409 PMC: 11315131. DOI: 10.1016/j.heliyon.2024.e34295.


Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response.

Coulton A, Murai J, Qian D, Thakkar K, Lewis C, Litchfield K Nat Commun. 2024; 15(1):5665.

PMID: 38969631 PMC: 11226649. DOI: 10.1038/s41467-024-49885-8.


References
1.
Karnevi E, Andersson R, Rosendahl A . Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion. Immunol Cell Biol. 2014; 92(6):543-52. DOI: 10.1038/icb.2014.22. View

2.
Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

3.
Marchesi M, Andersson E, Villabona L, Seliger B, Lundqvist A, Kiessling R . HLA-dependent tumour development: a role for tumour associate macrophages?. J Transl Med. 2013; 11:247. PMC: 3856519. DOI: 10.1186/1479-5876-11-247. View

4.
Hamid M, Wang R, Yao X, Fan P, Li X, Chang X . Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8 Tumor-Infiltrating T Lymphocyte Responses. Cancer Immunol Res. 2019; 7(8):1293-1306. DOI: 10.1158/2326-6066.CIR-18-0885. View

5.
Yang Z, Wei S, Deng Y, Wang Z, Liu L . Clinical significance of tumour mutation burden in immunotherapy across multiple cancer types: an individual meta-analysis. Jpn J Clin Oncol. 2020; 50(9):1023-1031. DOI: 10.1093/jjco/hyaa076. View